Related references
Note: Only part of the references are listed.Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience
Aravindhan Veerapandiyan et al.
MUSCLE & NERVE (2020)
Efficacy of nusinersen in type 1, 2 and 3 spinal muscular atrophy: Real world data from Hungarian patients
Lena Szabo et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2020)
Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study
Tim Hagenacker et al.
LANCET NEUROLOGY (2020)
Nusinersen in later-onset spinalmuscular atrophy Long-term results from the phase 1/2 studies
Basil T. Darras et al.
NEUROLOGY (2019)
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data
Marika Pane et al.
ANNALS OF NEUROLOGY (2019)
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials
Basil T. Darras et al.
CNS DRUGS (2019)
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
Darryl C. De Vivo et al.
NEUROMUSCULAR DISORDERS (2019)
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
E. Mercuri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Population Pharmacokinetics of Nusinersen in the Cerebral Spinal Fluid and Plasma of Pediatric Patients With Spinal Muscular Atrophy Following Intrathecal Administrations
Kenneth T. Luu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Natural history of infantile-onset spinal muscular atrophy
Stephen J. Kolb et al.
ANNALS OF NEUROLOGY (2017)
Diverse role of survival motor neuron protein
Ravindra N. Singh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2017)
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
Richard S. Finkel et al.
LANCET (2016)
209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7-9 November 2014, Heemskerk, The Netherlands
Richard Finkel et al.
NEUROMUSCULAR DISORDERS (2015)
Spinal Muscular Atrophies
Basil T. Darras
PEDIATRIC CLINICS OF NORTH AMERICA (2015)
Share Paper
